No significant differences were found in gender distribution, BM blast, PB blast, FAB subtypes other than M4 and frequent AML mutations (FLT3-ITD, NPM1, RUNX1, ASXL1, TP53, DNMT3A, IDH1/IDH2, and TET2). Here, TET2 is linked to acute myeloid leukemia.